Amanta Healthcare Q2 FY26 – Profitability Rebounds Despite Flat Sales

Amanta Healthcare posted muted top-line performance, with sales down 4% YoY to ₹65.3 crore in Q2 FY26. However, operating profit (EBIDT) grew 11% YoY to ₹14.9 crore, showing better cost control. The highlight was a sharp turnaround in profitability – net profit surged 1075% YoY to ₹3.51 crore compared to a loss last year, and EPS jumped 1038% to ₹1.22, marking a strong recovery in earnings. With the stock trading at ₹138, a market cap of ₹537 crore, and a PE ratio of 50.8, valuations appear overvalued despite improving fundamentals.